ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,571.33
0.13%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Oyster Point Pharma Inc (OYST)

  7. Oyster Point Pharma Inc (OYST) News

Oyster Point Pharma (OYST)

Oyster Point Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OYST
DateTimeSourceHeadlineSymbolCompany
14/02/202321:34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
14/02/202315:06Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OYSTOyster Point Pharma Inc
13/01/202322:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:OYSTOyster Point Pharma Inc
13/01/202322:06Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OYSTOyster Point Pharma Inc
06/01/202311:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202321:33Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
05/01/202321:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202323:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202322:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202322:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202322:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202322:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202322:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
04/01/202322:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202314:53Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202314:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202314:19Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:OYSTOyster Point Pharma Inc
03/01/202314:07Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
23/12/202211:31Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
22/12/202222:16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
21/12/202211:04Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OYSTOyster Point Pharma Inc
09/12/202212:01Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OYSTOyster Point Pharma Inc
09/12/202212:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OYSTOyster Point Pharma Inc
06/12/202213:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
05/12/202222:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OYSTOyster Point Pharma Inc
02/12/202213:00GlobeNewswire Inc.Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:OYSTOyster Point Pharma Inc
01/12/202212:39Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OYSTOyster Point Pharma Inc
01/12/202211:12Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OYSTOyster Point Pharma Inc
16/11/202221:25Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OYSTOyster Point Pharma Inc
14/11/202213:10Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OYSTOyster Point Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:OYST

Your Recent History

NASDAQ
ABBBWXX
Bank of Montreal Autocal...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved